Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.92 USD | +2.32% | +1.38% | +124.24% |
Jun. 02 | Transcript : Cullinan Therapeutics, Inc. - Special Call | |
Jun. 01 | Cullinan Therapeutics, Inc. Announces Positive Initial Data from Pivotal Phase 2b Rezil1 Study of Zipalertinib | CI |